ArticleDrug development research2020

Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections.

Robert C SpethPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.